Expression of Trefoil Factors and Adrenomedullin in Subjects With Chronic Periodontitis and Coronary Heart Disease
1 other identifier
observational
75
1 country
1
Brief Summary
To assess the demographic variables, periodontal parameters and to determine the expression of Trefoil factors 2 and 3 and Adrenomedullin in unstimulated saliva samples of periodontally healthy subjects with coronary heart disease and generalised chronic periodontitis subjects with and without coronary heart disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 14, 2019
CompletedStudy Start
First participant enrolled
October 14, 2019
CompletedFirst Posted
Study publicly available on registry
October 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2021
CompletedSeptember 2, 2020
September 1, 2020
1.2 years
October 14, 2019
September 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Trefoil factors 2 and 3 and Adrenomedullin expression in Chronic periodontitis patients with and without coronary heart disease
Expression of Trefoil factors 2 and 3 and Adrenomedullin using Enzyme Linked Immunosorbent Assay
12 months
Study Arms (3)
Group I
25 Generalized chronic periodontitis subjects without coronary heart disease.
Group II
25 Generalized chronic periodontitis subjects diagnosed with coronary heart disease.
Group III
25 Periodontally healthy subjects diagnosed with coronary heart disease.
Eligibility Criteria
Participants from 30 years to 65 years will be recruited for the study. Subjects would be categorized into the above mentioned three groups based on their medical status.
You may qualify if:
- Patients willing to participate in the study.
- Patients within the age group of 30-65 years.
- Patients should have ≥ 20 remaining natural teeth.
- For Group I
- Systemically healthy, Generalized chronic periodontitis subjects with 30% or more sites with clinical attachment loss (CAL) ≥ 2mm, radiographic evidence of alveolar crestal bone loss ≥ 2mm from the cemento-enamel junction.
- For Group II
- Generalized chronic periodontitis subjects with 30% or more sites with clinical attachment loss (CAL) ≥ 2mm, radiographic evidence of alveolar crestal bone loss ≥ 2mm from the cemento-enamel junction along with coronary heart disease.
- For Group III • Periodontally healthy subjects with Probing pocket depth (PD) less than 4mm, bleeding on probing (BOP) at ≤15% of tooth sites, no periodontal treatment (Scaling and root planing or periodontal surgery) within the previous 6 months and without evident clinical signs of gingival inflammation along with the presence of coronary heart disease.
You may not qualify if:
- Subjects with systemic conditions such as type I and type II diabetes mellitus, respiratory diseases, renal disease, liver disease, rheumatoid arthritis, allergy, advanced malignancies and HIV infection will be excluded from the present investigation.
- For Group I, subjects on drugs such as corticosteroids, antibiotics, within 6 months of investigation will be excluded.
- Current smokers and individuals who quit smoking less than 6 months.
- Patients who have undergone periodontal therapy within the previous 6 months.
- Pregnant women (pregnancy may alter the oral flora)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Meenakshi Ammal Dental College
Chennai, Tamil Nadu, 600095, India
Related Publications (2)
Chaiyarit P, Chayasadom A, Wara-Aswapati N, Hormdee D, Sittisomwong S, Nakaresisoon S, Samson MH, Pitiphat W, Giraud AS. Trefoil factors in saliva and gingival tissues of patients with chronic periodontitis. J Periodontol. 2012 Sep;83(9):1129-38. doi: 10.1902/jop.2011.110431. Epub 2011 Dec 19.
PMID: 22181686BACKGROUNDSuchetha A, Garg A, Lakshmi P, Bhat D, Sapna N, Apoorva SM. Adrenomedullin, periodontitis, diabetes-unraveling the equivocal relationship: A clinicobiochemical cross-sectional study. Contemp Clin Dent. 2013 Oct;4(4):454-9. doi: 10.4103/0976-237X.123040.
PMID: 24403788BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jaideep Mahendra, MDS, PhD
Meenakshi Ammal Dental College
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, PhD guide, Director of Post Graduate Studies
Study Record Dates
First Submitted
October 14, 2019
First Posted
October 15, 2019
Study Start
October 14, 2019
Primary Completion
December 20, 2020
Study Completion
November 20, 2021
Last Updated
September 2, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share